De Novo Pharmaceuticals

Established in 1999, De Novo Pharmaceuticals was the first start-up company to be spun out of the University of Cambridge Department of Pharmacology. In April 2000 the company secured a funding commitment of £2m from investors Prelude Trust, Avlar Bioventures and Cambridge Research and Innovation, of which just over a million was drawn down at the time, with the provision of the balance dependent on De Novo meeting certain objectives set by the investors. It has now been announced that the company has successfully met these requirements and the second tranche of £950,000 has been drawn down. In the year since receiving the first tranche, De Novo has increased its staff from six to 23, has developed a technology partnering programme with several US biotech companies and has submitted its first patent applications.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland